Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Shanghai, SH, CN. The stock last traded at $1.95, up 0.00% on the session, giving a market capitalisation of $5.16B. On trailing twelve-month figures it carries a trailing P/E of 18.37, a net margin of 8.2%. Its beta of 0.44 implies it has historically moved less than the broad market.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF), founded in 1994 and based in Shanghai, China, is a comprehensive pharmaceutical enterprise. The company is actively engaged in the research, development, manufacturing, and sale of pharmaceutical products, serving markets across Mainland China and internationally. Its diverse operations are structured into five main segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Services, Pharmaceutical Distribution and Retail, and Other Business activities. Within its pharmaceutical portfolio, Fosun Pharma focuses on critical therapeutic areas such as oncology, immune system modulation, metabolic disorders, gastrointestinal conditions, and central nervous system ailments. Beyond its drug offerings, the company also provides a range of medical equipment and diagnostic solutions. Furthermore, SFOSF is involved in delivering healthcare services and managing hospitals, alongside its wholesale and retail distribution of medicines.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is most often compared with the following Healthcare names: